The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertMasernfälle in den USA bis zum 30. April?
Masernfälle in den USA bis zum 30. April?
$479,297 Vol.
30. Apr. 2026
1750
Ja
1775
Ja
1800
Nein
1900
Nein
1850
Nein
2000
Nein
1950
Nein
2100
Nein
2200
Nein
$479,297 Vol.
1750
$21,777 Vol.
Ja
1775
$39,332 Vol.
Ja
1800
$168,010 Vol.
Nein
1900
$74,279 Vol.
Nein
1850
$27,965 Vol.
Nein
2000
$57,355 Vol.
Nein
1950
$36,078 Vol.
Nein
2100
$18,603 Vol.
Nein
2200
$35,898 Vol.
Nein
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Markt eröffnet: Apr 16, 2026, 10:34 AM ET
Volumen
$479,297Enddatum
30. Apr. 2026Markt eröffnet
Apr 16, 2026, 10:34 AM ETResolver
0x65070BE91...Vorgeschlagenes Ergebnis: Ja
Kein Einspruch
Endgültiges Ergebnis: Ja
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$479,297Enddatum
30. Apr. 2026Markt eröffnet
Apr 16, 2026, 10:34 AM ETResolver
0x65070BE91...Vorgeschlagenes Ergebnis: Ja
Kein Einspruch
Endgültiges Ergebnis: Ja
The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen